Check out the companies making headlines in midday trading. Tech stocks – Shares of megacap technology names rose amid investor optimism that the U.S. would reach deals with other countries to lower tariffs. Apple – which lost around 20% in the past three trading days given its China exposure – rose more than 3%. Others like Nvidia and Tesla also gained, rising about 6% and nearly 5%, respectively. UnitedHealth Group , Humana – The leading health insurance stocks jumped after the Center for Medicare & Medicaid Services announced a higher-than-expected hike for government payments to Medicare Advantage plans. Shares of UnitedHealth rose 6.7%, while Humana’s stock surged 10.8%. Wells Fargo – The bank stock climbed nearly 4% after Piper Sandler upgraded Wells Fargo to overweight from neutral . Piper said the banking giant’s stock has an attractive valuation that appropriately captured the company’s improving fortunes. Broadcom – The chip stock gained more than 7% after the company authorized a $10 billion share repurchase program through the end of 2025. The authorization announcement “reflects the board’s confidence in the strength of Broadcom’s diversified semiconductor and infrastructure software product franchises,” said chief executive Hock Tan in a statement . Marvell Technology – Shares popped more than 7% following the company’s agreement to sell its auto ethernet business to Infineon Technologies in an all-cash deal valued at $2.5 billion. The deal is expected to close within 2025. Lockheed Martin — Shares popped 4% amid a broader advance in defense companies, after President Donald Trump pledged a $1 trillion defense budget for the full year. Janover – The stock fell more than 31%, reversing course from its more than 800% rally in the previous session, after the software company announced a crypto treasury strategy that would be focused on the Solana token . Janover also plans to revise its name and ticker symbol. Charles Schwab – The financial stock popped 4.5% on the heels of Morgan Stanley’s upgrade to overweight from equal weight . Morgan Stanley said it’s prioritizing brokers with defensive revenue sources and idiosyncratic drivers for earnings growth. Eli Lilly – The pharma stock added 3% after Goldman Sachs assumed coverage of the name at a buy rating. Analyst Asad Haider said that he sees a “compelling entry point” for the stock at its current levels. Greenbrier – The railcar manufacturer lost 4% after slashing its full-year revenue guidance. Greenbrier now expects revenue between $3.15 billion to $3.35 billion, versus its earlier guidance of $3.35 billion to $3.65 billion. Tilray Brands – Shares plummeted more than 11% after the company posted weaker-than-expected third-quarter results. Tilray reported adjusted EBITDA of $9 million, below the $9.7 million that analysts polled by FactSet were expecting. For net revenue, the company recorded $185.8 million, likewise below the consensus estimate of $210 million. Tilray also narrowed its full-year forecast. — CNBC’s Alex Harring, Jesse Pound, Sarah Min, Yun Li, Lisa Kailai Han and Michelle Fox contributed reporting.
Check out the companies making headlines in extended trading. Palantir Technologies — Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street’s expectations. Adjusted earnings of 13 cents per share came in-line with the consensus estimate, per LSEG. Palantir reported $884 million in revenue, topping the $863 million forecast by analysts. Vertex Pharmaceuticals — The biotech stock dropped 2% on disappointing quarterly results. Adjusted earnings came in at $4.06 per share, below the $4.32 per share forecast by analysts surveyed by LSEG. Revenue of $2.77 billion also missed analysts’ estimates for $2.85 billion. Mattel — Shares of the toymaker declined 2.5% after management paused its 2025 full-year guidance due to tariff uncertainty. Meanwhile, first-quarter results topped analysts’ estimates. Neurocrine Biosciences — The maker of neurological drugs jumped 11% postmarket after first-quarter revenue of $572.6 million topped a $559.6 million estimate from analysts surveyed by FactSet. Sales of Ingrezza, used to treat movement disorders, rose 8% year-over-year to $545 million. Lattice Semiconductor — The chip stock fell 3.8% after first-quarter earnings and revenue both were in-line with consensus estimates. Lattice guided toward current quarter revenue between $118.5 million to $128.5 million, while analysts polled by LSEG expected $123.6 million. Adjusted earnings are estimated to range from 22 cents to 26 cents per share, versus the 24 cents per share analysts were looking for. Hims & Hers Health — The telehealth company dropped 1%. Guidance for second-quarter revenue came in lighter than expected, ranging from $530 million to $550 million, while analysts polled by FactSet sought $564.6 million. Earnings and revenue for the first quarter surpassed the Street’s expectations, however. Ford Motor — The maker of F-series pickup trucks fell 2.7% after hours on first-quarter results showing earnings ex-items before interest and taxes (EBIT) plunged to $1.02 billion from $2.76 billion a year ago, according to FactSet. Ford estimated the net cost of higher tariffs on EBIT in 2025 at about $1.5 billion and withdrew forward guidance. Clorox – Shares of the cleaning products manufacturer fell 2.8%. Clorox posted adjusted earnings of $1.45 per share on revenue of $1.67 billion in the fiscal third quarter. That fell short of analysts’ call for $1.57 per share in earnings and $1.73 billion in revenue, per LSEG. Diamondback Energy – The energy stock advanced nearly 1% after reporting better-than-expected results. Diamondback earned $4.54 per share, ex-items, in the first quarter, topping FactSet consensus estimates for $4.18 per share. Cash capital expenditures of $942 million in the period was less than the $952.8 million forecast by Wall Street. — CNBC’s Darla Mercado and Scott Schnipper contributed reporting
Check out the companies making headlines in midday trading: Berkshire Hathaway — Warren Buffett’s conglomerate saw shares drop more than 4%, retreating from record highs reached on Friday. Monday’s sell-off came after the 94-year-old Buffett announced his intention to step down as CEO. The board voted unanimously on Sunday to make Greg Abel president and CEO on Jan. 1, 2026, and for Buffett to remain as chairman. Meanwhile, Berkshire’s operating earnings fell 14% in the first quarter , driven by a 48.6% plunge in insurance-underwriting profit. On Semiconductor — Shares tumbled more than 8% despite the chipmaker’s top- and bottom-line beat in the first quarter. On also issued second-quarter guidance, estimating adjusted earnings coming in between 48 cents and 58 cents per share, while analysts polled by FactSet forecast 51 cents per share. Top-line guidance between $1.4 billion and $1.5 billion also mostly came above consensus estimates for $1.41 billion. Skechers USA — Shares of the footwear company surged nearly 25% after it agreed to be acquired by 3G Capital for $63 per share . Other footwear stocks rose in sympathy following the announcement. Crocs gained almost 5%, while Deckers advanced more than 2%. Tyson Foods — Shares of the Jimmy Dean and Hillshire Farm parent slipped almost 8% after revenue for the second fiscal quarter came in at $13.07 billion, missing the consensus forecast of $13.14 billion from analysts polled by FactSet. However, Tyson posted earnings of 92 cents per share, excluding items, beating the Wall Street estimate of 83 cents per share. Howard Hughes — The stock added 3.7% after activist investor Bill Ackman’s Pershing Square agreed to buy nine million newly issued shares of the real estate developer. The hedge fund is paying $100 per share, which represents a 48% premium to Howard Hughes’ closing price on Friday. Sunoco — Shares fell nearly 6% after the motor fuel distributor shared its plan to acquire Parkland, a Canada-based competitor. The cash-and-stock deal is valued at more than $9 billion, which includes debt. Loews — Shares of the conglomerate pulled back 1.3% after the company’s first-quarter report showed a drop in earnings. Loews reported $370 million in net income for the period, or $1.74 per share, down from $457 million and $2.05 per share a year earlier. The company saw net income declines in its insurance and hotel businesses. Streamers — Streaming stocks declined after President Donald Trump announced Sunday in a Truth Social post a 100% tariff on movies produced outside of the U.S. to save the “dying” American movie industry. Netflix lost more than 1%. Amazon , Paramount Global and Warner Bros. Discovery each shed roughly 1%. EQT — The natural gas stock popped almost 3% following UBS’ upgrade to buy from neutral. UBS called the stock “well positioned” to capture upside tied to the firm’s positive outlook for natural gas next year. Wendy’s — The fast-food chain added 1% on the back of JPMorgan’s upgrade to overweight from neutral. JPMorgan said the stock’s current share price offers a “value-oriented opportunity” for investors. Sotera Health — Shares jumped nearly 5% after Goldman Sachs upgraded the testing lab company’s stock to buy from neutral. Goldman said the company has a “durable” business model and should be able to withstand an economic downturn. — CNBC’s Sean Conlon, Lisa Kailai Han, Hakyung Kim, Michelle Fox, Jesse Pound and Yun Li contributed reporting.
People watch as Berkshire Hathaway chairman Warren Buffett is seen on a screen speaking at the Berkshire Hathaway Inc annual shareholders’ meeting, in Omaha, Nebraska, U.S., May 3, 2025.
Brendan McDermid | Reuters
Berkshire Hathaway shares are hanging on solidly Monday as investors process Warren Buffett‘s surprise announcement to step down and envision a new path for the conglomerate after his legendary 60-year run.
Buffett, 94, picked the very last moment at Berkshire’s annual meeting in Omaha, Nebraska, to tell his loyal shareholders that it’s time for Greg Abel, vice chairman of non-insurance operations, to replace him as CEO. The board voted unanimously on Sunday to make Abel president and CEO on Jan. 1, 2026, and for Buffett to remain as chairman.
Class B shares fell 2.9% in premarket trading Monday after hitting an all-time high at $539.80 Friday. Class A shares dropped 2.8% after closing at a record high at $809,350 apiece. Berkshire issued Class B shares in 1996 at a price equal to one-thirtieth of a Class A share. In 2010, Berkshire Class B shares split 50-for-1.
“Shareholders should welcome this transparent transition, but also have confidence that Warren isn’t going anywhere,” said Macrae Sykes, portfolio manager at Gabelli Funds and a Berkshire shareholder. “Retaining the position of Chairman means he can continue to mentor Greg and the Berkshire leaders, while also providing additional intellectual capacity when the inevitable time for more major capital allocation occurs.”
It marks an end of an epic era for Berkshire, which was a failing New England textile mill six decades ago when Buffett used an investment partnership he ran to take control. Berkshire has grown into a one-of-a-kind juggernaut worth nearly $1.2 trillion with businesses encompassing insurance, railroad, retail, manufacturing and energy. Buffett is handing over his reins on a particularly high note as Berkshire shares just reached a new peak Friday.
Berkshire Hathaway Class B shares
“Buffett leaves a company that is less reliant on his investing capabilities, with an array of leading businesses with strong cash flows,” Brian Meredith, UBS’ Berkshire analyst, said in a note. “Operationally, we expect little change at BRK and the culture/strategy to remain unchanged under Abel.”
The stock could also be reacting to Berkshire’s first-quarter results that showed a 14% decline in operating earnings, driven by a 48.6% plunge in insurance-underwriting profit. Berkshire said the Southern California wildfires led to a $1.1 billion loss during the period.
Berkshire shares have significantly outperformed the S&P 500, rising nearly 19% this year. Investors seeking relatively safe places to hide find Berkshire appealing because of the defensive nature of its huge insurance empire and the conglomerate’s unmatched balance sheet.